<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title>PLoS Pathogens</journal-title><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PLPA-RA-0917R2</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1000235</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Macromolecular Assemblies and Machines</subject><subject>Biophysics/Biomacromolecule-Ligand Interactions</subject><subject>Cell Biology/Cell Adhesion</subject><subject>Infectious Diseases/Infectious Diseases of the Nervous System</subject><subject>Infectious Diseases/Viral Infections</subject></subj-group></article-categories><title-group><article-title>Structure of Reovirus &#x003c3;1 in Complex with Its Receptor Junctional Adhesion Molecule-A</article-title><alt-title alt-title-type="running-head">The Reovirus &#x003c3;1-JAM-A Complex</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kirchner</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guglielmi</surname><given-names>Kristen M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Strauss</surname><given-names>Holger M.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dermody</surname><given-names>Terence S.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stehle</surname><given-names>Thilo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Interfaculty Institute for Biochemistry, University of Tuebingen, Tuebingen, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Nanolytics Gesellschaft f&#x000fc;r Kolloidanalytik mbH, Potsdam, Germany</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rey</surname><given-names>F&#x000e9;lix A.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Institut Pasteur, France</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>terry.dermody@vanderbilt.edu</email> (TSD); <email>thilo.stehle@uni-tuebingen.de</email> (TS)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: EK KMG HMS TSD TS. Performed the experiments: EK KMG HMS. Analyzed the data: EK KMG HMS TSD TS. Wrote the paper: EK KMG TSD TS.</p></fn></author-notes><pub-date pub-type="collection"><month>12</month><year>2008</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 --><pub-date pub-type="ppub"><month>12</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2008</year></pub-date><volume>4</volume><issue>12</issue><elocation-id>e1000235</elocation-id><history><date date-type="received"><day>13</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2008</year></date></history><copyright-statement>Kirchner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Viral attachment to specific host receptors is the first step in viral infection and serves an essential function in the selection of target cells. Mammalian reoviruses are highly useful experimental models for studies of viral pathogenesis and show promise as vectors for oncolytics and vaccines. Reoviruses engage cells by binding to carbohydrates and the immunoglobulin superfamily member, junctional adhesion molecule-A (JAM-A). JAM-A exists at the cell surface as a homodimer formed by extensive contacts between its N-terminal immunoglobulin-like domains. We report the crystal structure of reovirus attachment protein &#x003c3;1 in complex with a soluble form of JAM-A. The &#x003c3;1 protein disrupts the JAM-A dimer, engaging a single JAM-A molecule via virtually the same interface that is used for JAM-A homodimerization. Thus, reovirus takes advantage of the adhesive nature of an immunoglobulin-superfamily receptor by usurping the ligand-binding site of this molecule to attach to the cell surface. The dissociation constant (K<sub>D</sub>) of the interaction between &#x003c3;1 and JAM-A is 1,000-fold lower than that of the homophilic interaction between JAM-A molecules, indicating that JAM-A strongly prefers &#x003c3;1 as a ligand. Analysis of reovirus mutants engineered by plasmid-based reverse genetics revealed residues in &#x003c3;1 required for binding to JAM-A and infectivity of cultured cells. These studies define biophysical mechanisms of reovirus cell attachment and provide a platform for manipulating reovirus tropism to enhance vector targeting.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Mammalian orthoreoviruses (reoviruses) are useful models for studies of virus&#x02013;receptor interactions and viral pathogenesis. They are closely related in structure to adenoviruses and share similar mechanisms of cell attachment and entry. The receptor for reovirus, junctional adhesion molecule-A (JAM-A), is a component of cellular junctions and also used as a receptor by feline calicivirus. To better understand how viruses engage cellular receptors, we determined the structure of reovirus attachment protein &#x003c3;1 bound to JAM-A. The structure provides an understanding of the biological function of the interaction and yields information that may enable targeting of reovirus to alternate receptors. Since the repertoire of receptors bound by a virus contributes importantly to determining which types of cells are infected, such targeting plays an essential role in gene delivery for vaccine or therapeutic applications. New cancer therapy approaches include the use of viruses, including reovirus, to lyse tumor cells. New knowledge about reovirus attachment to cellular receptors at an atomic level will help to harness the therapeutic potential of this virus.</p></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Viruses have evolved a variety of strategies to engage cellular receptors, often taking advantage of the adhesive properties of these molecules. Immunoglobulin superfamily (IgSF) members mediate cellular adhesion functions including antigen recognition, stabilization of intercellular junctions, adhesion to extracellular matrices, and leukocyte extravasation <xref ref-type="bibr" rid="ppat.1000235-Albelda1">&#x0005b;1&#x0005d;</xref>. These cell-surface proteins are also used as receptors by many viruses <xref ref-type="bibr" rid="ppat.1000235-Vogelmann1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Wang1">&#x0005b;3&#x0005d;</xref>. Junctional adhesion molecule-A (JAM-A) is an IgSF member that mediates cell-cell contacts and serves as a receptor for mammalian orthoreovirus (reovirus) <xref ref-type="bibr" rid="ppat.1000235-Barton1">&#x0005b;4&#x0005d;</xref> and feline calicivirus <xref ref-type="bibr" rid="ppat.1000235-Makino1">&#x0005b;5&#x0005d;</xref>. Reovirus serves as a tractable experimental model for studies of virus-receptor interactions and viral pathogenesis. Virtually all mammals including humans serve as hosts for reovirus infection, but disease is restricted to the very young <xref ref-type="bibr" rid="ppat.1000235-Schiff1">&#x0005b;6&#x0005d;</xref>. The recent development of plasmid-based reverse genetics for reovirus offers the opportunity to manipulate these viruses for oncolytic and vaccine applications <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref>.</p><p>Reoviruses form icosahedral particles approximately 850 &#x000c5; in diameter <xref ref-type="bibr" rid="ppat.1000235-Schiff1">&#x0005b;6&#x0005d;</xref>. At the virion fivefold symmetry axes, the trimeric attachment protein, &#x003c3;1, extends from pentameric turrets formed by the &#x003bb;2 protein <xref ref-type="bibr" rid="ppat.1000235-Fraser1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Furlong1">&#x0005b;9&#x0005d;</xref>. A similar arrangement of a trimeric attachment protein inserted into a pentameric base is also observed for the adenovirus attachment protein, fiber <xref ref-type="bibr" rid="ppat.1000235-Stewart1">&#x0005b;10&#x0005d;</xref>. The &#x003c3;1 molecule is about 480 &#x000c5; in length and composed of a filamentous N-terminal tail and a globular C-terminal head <xref ref-type="bibr" rid="ppat.1000235-Fraser1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Furlong1">&#x0005b;9&#x0005d;</xref>. Discrete regions of the molecule mediate binding to cell-surface receptors. Sequences in the tail bind to carbohydrate <xref ref-type="bibr" rid="ppat.1000235-Chappell1">&#x0005b;11&#x0005d;</xref>, which is &#x003b1;-linked sialic acid for serotype 3 reoviruses <xref ref-type="bibr" rid="ppat.1000235-Chappell2">&#x0005b;12&#x0005d;</xref>. The &#x003c3;1 head binds to JAM-A <xref ref-type="bibr" rid="ppat.1000235-Barton1">&#x0005b;4&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>.</p><p>Structural analysis of the C-terminal region of strain type 3 Dearing (T3D) &#x003c3;1, which includes the region that binds to JAM-A <xref ref-type="bibr" rid="ppat.1000235-Barton1">&#x0005b;4&#x0005d;</xref>, has revealed details of its trimeric structure <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>. Residues forming the head consist of two Greek-key motifs that fold into a compact &#x003b2;-barrel. The topology of this structure is identical to the &#x003b2;-sandwich that forms the receptor-binding knob of adenovirus fiber, pointing to a distant evolutionary relationship between the two proteins <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>. Loops connecting individual strands of the &#x003c3;1 &#x003b2;-barrel are short with the exception of the D&#x02013;E loop (connecting &#x003b2;-strands D and E), which contains a 3<sub>10</sub> helix. N-terminal residues in the crystallized fragment form a portion of the tail, which consists of three triple &#x003b2;-spiral repeats. To date, the triple &#x003b2;-spiral motif has been observed only in adenovirus fiber <xref ref-type="bibr" rid="ppat.1000235-vanRaaij1">&#x0005b;15&#x0005d;</xref>, bacteriophage PRD1 spike <xref ref-type="bibr" rid="ppat.1000235-Merckel1">&#x0005b;16&#x0005d;</xref>, and avian reovirus attachment protein &#x003c3;C <xref ref-type="bibr" rid="ppat.1000235-Guardado1">&#x0005b;17&#x0005d;</xref>.</p><p>JAM-A is an important component of tight junctions between endothelial and epithelial cells <xref ref-type="bibr" rid="ppat.1000235-Liu1">&#x0005b;18&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-MartinPadura1">&#x0005b;19&#x0005d;</xref>. It is also expressed on the surface of platelets and leukocytes <xref ref-type="bibr" rid="ppat.1000235-Williams1">&#x0005b;20&#x0005d;</xref>. JAM-A influences the migration of leukocytes across endothelial and epithelial barriers in response to inflammatory cues <xref ref-type="bibr" rid="ppat.1000235-DelMaschio1">&#x0005b;21&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Woodfin1">&#x0005b;22&#x0005d;</xref>. The extracellular portion of JAM-A forms a homodimer in which the monomers are partially intertwined via interactions of the membrane-distal D1 domains <xref ref-type="bibr" rid="ppat.1000235-Kostrewa1">&#x0005b;23&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>. Interestingly, the only other example of structurally similar homodimeric interactions by an IgSF member is the coxsackievirus and adenovirus receptor, CAR <xref ref-type="bibr" rid="ppat.1000235-vanRaaij2">&#x0005b;25&#x0005d;</xref>.</p><p>Domain-swapping experiments indicate that the D1 domain of JAM-A is necessary for functional interactions with reovirus <xref ref-type="bibr" rid="ppat.1000235-Forrest1">&#x0005b;26&#x0005d;</xref>. Thus, our efforts to identify &#x003c3;1-binding regions in JAM-A have focused on D1. Biochemical studies have identified the dimer interface as the region of JAM-A bound by reovirus &#x003c3;1, and individual residues in JAM-A that are required for efficient &#x003c3;1 binding are located within this interface <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Forrest1">&#x0005b;26&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. In addition, complexes formed between purified &#x003c3;1 head domain and purified dimeric wild-type (wt) or monomeric point-mutant forms of JAM-A are indistinguishable by size-exclusion chromatography <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>, suggesting that a monomeric form of JAM-A serves as the relevant binding partner for &#x003c3;1.</p><p>To define the structural basis of &#x003c3;1-JAM-A interactions, we crystallized a complex of the head domain of T3D &#x003c3;1 and the D1 domain of human JAM-A (hJAM-A) and determined its structure at 3.4 &#x000c5; resolution. Since &#x003c3;1 binds to a monomeric form of JAM-A, we determined the dissociation constant (K<sub>D</sub>) of the homophilic JAM-A interaction by analytical ultracentrifugation to define the stability of the JAM-A dimer and the mechanism of &#x003c3;1-JAM-A complex formation. Finally, we used plasmid-based reverse genetics to engineer reoviruses expressing mutant forms of &#x003c3;1 to determine the contributions to binding and infectivity of specific residues that contact JAM-A. These studies reveal the biochemical basis of &#x003c3;1-JAM-A interactions, provide clues about how &#x003c3;1 successfully competes for the JAM-A dimer interface, and establish a platform for fine-tuning receptor recognition to enhance the targeting of reovirus vectors.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Complex Formation and Crystallization</title><p>A T3D &#x003c3;1 fragment comprising the head domain and one &#x003b2;-spiral of the tail (&#x003c3;1H; residues 293&#x02013;455) and the D1 domain of hJAM-A (D1; residues 28&#x02013;129) were purified using glutathione S-transferase (GST)-affinity purification <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. The domain boundaries were chosen to eliminate regions of known flexibility <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> and retain binding capacity <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. Purified &#x003c3;1H was mixed with an excess of D1 to ensure saturation of binding. Following incubation, &#x003c3;1H-D1 complexes were separated from excess D1 by size-exclusion chromatography and crystallized.</p><p>The structure of the &#x003c3;1H-D1 complex was determined by molecular replacement and refined to 3.4 &#x000c5; resolution (<xref ref-type="table" rid="ppat-1000235-t001">Table 1</xref>). The crystallographic asymmetric unit consists of two &#x003c3;1H trimers, each bound to three D1 monomers. The presence of six independent copies enabled us to carry out six-fold non-crystallographic averaging of the components and refinement using non-crystallographic symmetry restraints. These techniques helped to establish a reliable model in which the main chain and most of the side chains, including those at the contact interface, are defined by satisfactory electron density. Real-space correlation plots show that the structure is in good agreement with the electron density (<xref ref-type="supplementary-material" rid="ppat.1000235.s001">Figure S1</xref>). The dataset was assembled from three individual crystals, which may explain the relatively high merging <italic>R</italic>-factor of 16.3&#x00025; (<italic>R</italic><sub>merge</sub>, <xref ref-type="table" rid="ppat-1000235-t001">Table 1</xref>). In contrast, the refinement <italic>R</italic>-factor is relatively low at 21.0&#x00025; (<italic>R</italic><sub>work</sub>, <xref ref-type="table" rid="ppat-1000235-t001">Table 1</xref>). Because of sixfold non-crystallographic symmetry in the crystals, our free set of reflections, used as a control for the <italic>R</italic>-factor during refinement, is most likely not totally &#x0201c;free.&#x0201d;</p><table-wrap id="ppat-1000235-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.t001</object-id><label>Table 1</label><caption><title>Data collection and refinement statistics.</title></caption><graphic id="ppat-1000235-t001-1" xlink:href="ppat.1000235.t001"/><table frame="hsides" rules="groups" alternate-form-of="ppat-1000235-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><tbody><tr><td colspan="2" align="left" rowspan="1"><bold>Data collection</bold><xref ref-type="table-fn" rid="nt101">a</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Space group</td><td align="left" rowspan="1" colspan="1">P2<sub>1</sub>2<sub>1</sub>2</td></tr><tr><td align="left" rowspan="1" colspan="1">Unit cell dimensions (&#x000c5;)</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;105.9, <italic>b</italic>&#x0200a;&#x0003d;&#x0200a;124.3, <italic>c</italic>&#x0200a;&#x0003d;&#x0200a;130.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">30.00&#x02013;3.40 (3.52&#x02013;3.40)<xref ref-type="table-fn" rid="nt102">b</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>merge</sub> (&#x00025;)<xref ref-type="table-fn" rid="nt103">c</xref></td><td align="left" rowspan="1" colspan="1">16.3 (21.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>I/&#x003c3;I</italic></td><td align="left" rowspan="1" colspan="1">6.9 (2.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Completeness (&#x00025;)</td><td align="left" rowspan="1" colspan="1">90.2 (69.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Redundancy</td><td align="left" rowspan="1" colspan="1">3.6 (1.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>B</italic>-factor from Wilson plot (&#x000c5;<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">64.5</td></tr><tr><td colspan="2" align="left" rowspan="1"><bold>Refinement</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">30.00&#x02013;3.40 (3.52&#x02013;3.40)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. reflections</td><td align="left" rowspan="1" colspan="1">21,954</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>work</sub> / <italic>R</italic><sub>free</sub> (&#x00025;)<xref ref-type="table-fn" rid="nt104">d</xref></td><td align="left" rowspan="1" colspan="1">21.0 (28.4) / 25.2 (32.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">No. atoms</td><td align="left" rowspan="1" colspan="1">12,227</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>B</italic>-factor (&#x000c5;<sup>2</sup>), overall</td><td align="left" rowspan="1" colspan="1">62.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>B</italic>-factor (&#x000c5;<sup>2</sup>), &#x003c3;1H</td><td align="left" rowspan="1" colspan="1">56.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>B</italic>-factor (&#x000c5;<sup>2</sup>), D1</td><td align="left" rowspan="1" colspan="1">71.8</td></tr><tr><td align="left" rowspan="1" colspan="1">R.m.s.d. Bond lengths (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">0.011</td></tr><tr><td align="left" rowspan="1" colspan="1">R.m.s.d. Bond angles (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">1.544</td></tr><tr><td colspan="2" align="left" rowspan="1"><italic>Ramachandran plot:</italic><xref ref-type="table-fn" rid="nt105">e</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Residues in favoured region (&#x00025;)</td><td align="left" rowspan="1" colspan="1">91.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Residues in allowed region (&#x00025;)</td><td align="left" rowspan="1" colspan="1">8.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Residues in outlier region (&#x00025;)</td><td align="left" rowspan="1" colspan="1">0.1</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>a</label><p>Three crystals were used to assemble the dataset.</p></fn><fn id="nt102"><label>b</label><p>Values in parentheses are for highest resolution shell.</p></fn><fn id="nt103"><label>c</label><p><italic>R</italic><sub>merge</sub>&#x0200a;&#x0003d;&#x0200a;&#x02211;<italic><sub>hkl</sub></italic> |<italic>I&#x02212;&#x0003c;I&#x0003e;</italic>|/&#x02211;<italic><sub>hkl</sub> I</italic>, where <italic>I</italic> is the intensity of a reflection <italic>hkl</italic>, and <italic>&#x0003c;I&#x0003e;</italic> the average over symmetry-related observations of <italic>hkl</italic>.</p></fn><fn id="nt104"><label>d</label><p><italic>R</italic><sub>cryst</sub>&#x0200a;&#x0003d;&#x0200a;&#x02211;<italic><sub>hkl</sub></italic> |<italic>F</italic><sub>obs</sub>&#x02212;<italic>F</italic><sub>calc</sub>|/&#x02211;<italic><sub>hkl</sub> F</italic><sub>obs</sub>, where <italic>F</italic><sub>obs</sub> and <italic>F</italic><sub>calc</sub> are observed and calculated structure factors, respectively. Free set <xref ref-type="bibr" rid="ppat.1000235-Brnger2">&#x0005b;65&#x0005d;</xref> contains 10&#x00025; of the data. Free reflections were selected randomly.</p></fn><fn id="nt105"><label>e</label><p>Calculated with Rampage <xref ref-type="bibr" rid="ppat.1000235-CCP41">&#x0005b;55&#x0005d;</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b"><title>Overall Structure of the Complex</title><p>The crystallized complex consists of a &#x003c3;1H trimer ligated by three D1 monomers. When viewed along the three-fold non-crystallographic symmetry axis, its overall structure resembles a three-bladed propeller, with &#x003c3;1H forming the hub and D1 forming the blades (<xref ref-type="fig" rid="ppat-1000235-g001">Figure 1A</xref>). Each D1 monomer interacts with one &#x003c3;1H monomer, making extensive contacts that shield a combined area (the sum of contact areas on both proteins) of 1622 &#x000c5;<sup>2</sup> from solvent. Crystal packing results in additional contacts between the molecules. However, the interactions we describe are common to all &#x003c3;1H-D1 pairs and likely represent the physiologic complex interface. D1 residues involved in contact formation are located at the most membrane-distal (top) part of the domain and on the face that mediates homodimer formation. These regions in D1 pack tightly into a recessed region of &#x003c3;1H just below the &#x003b2;-barrel (<xref ref-type="fig" rid="ppat-1000235-g001">Figure 1B and 1C</xref>). Residues at the D1 dimer interface form extensive contacts with the D&#x02013;E loop and 3<sub>10</sub> helix of &#x003c3;1H at the upper boundary of the recessed region, whereas the top of D1 contacts residues in the &#x003b2;-spiral of the &#x003c3;1H tail at its lower boundary. In comparison to structures of isolated &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref> and hJAM-A <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>, the architecture of both &#x003c3;1H and D1 in the complex are largely preserved. Differences are observed primarily in side-chain orientations at the interfaces between &#x003c3;1H and D1.</p><fig id="ppat-1000235-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g001</object-id><label>Figure 1</label><caption><title>Structure of the &#x003c3;1H-D1 complex.</title><p>(A,B) Ribbon drawings of the complex between trimeric &#x003c3;1H and monomeric D1, viewed along the three-fold symmetry axis (A) and from the side (B). &#x003c3;1H monomers are shown in blue, yellow, and red; D1 is shown in green. (C) Surface representation of the contact area of reovirus &#x003c3;1H (left, orange) and D1 (right, green). Interacting partners are shown as ribbon traces. (D) Ribbon drawings of D1 (left) and &#x003c3;1H (right). Secondary structure elements are labeled. Contact residues (distance cut-off 4 &#x000c5;) in the &#x003c3;1H-D1 interface are colored green (D1) or orange (&#x003c3;1H).</p></caption><graphic xlink:href="ppat.1000235.g001"/></fig><p>Four of the six &#x003c3;1H-D1 pairs present in the asymmetric unit have similar structures and feature the same interactions. The analysis of the complex presented here is based on these pairs. The remaining two &#x003c3;1H-D1 pairs exhibit larger intermolecular distances of up to 1.2 &#x000c5;, resulting in fewer contacts and higher crystallographic temperature factors. The total buried surface area for these two interacting pairs is about 60 &#x000c5;<sup>2</sup> less. Crystal packing is very tight for a protein complex of this size, with only 50&#x00025; solvent content <xref ref-type="bibr" rid="ppat.1000235-Matthews1">&#x0005b;28&#x0005d;</xref>. The largest gaps in the packing occur directly beneath the D1 chains that exhibit larger intermolecular distances to &#x003c3;1H. Flash-cooling of crystals prior to data collection may have partially dislodged D1 from its binding site at these locations <xref ref-type="bibr" rid="ppat.1000235-Rodgers1">&#x0005b;29&#x0005d;</xref>.</p></sec><sec id="s2c"><title>Interaction of Reovirus &#x003c3;1H with JAM-A D1</title><p>Reovirus &#x003c3;1H engages JAM-A D1 using two main contact areas: a larger region centered at the D&#x02013;E loop and its 3<sub>10</sub> helix, just below the &#x003b2;-barrel, and a smaller region formed by the top of the &#x003b2;-spiral and the &#x003b1;-helix (<xref ref-type="fig" rid="ppat-1000235-g001">Figure 1D</xref>). These two regions resemble &#x0201c;jaws&#x0201d; that grip the D1 domain at its interdomain interface and top (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2A</xref>). Although exact placement of individual atoms is not possible at 3.4 &#x000c5; resolution, there is unambiguous electron density in an omit map for all side chains in the interface (<xref ref-type="fig" rid="ppat-1000235-g003">Figure 3</xref>), allowing for assignment of contacts.</p><fig id="ppat-1000235-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g002</object-id><label>Figure 2</label><caption><title>Contacts at the &#x003c3;1H-D1 interface.</title><p>(A) Overview displaying the location of residues in the &#x003c3;1H-D1 complex shown in (B) and (C) (upper jaw) and (D) (lower jaw). D1 and &#x003c3;1H are colored green and orange, respectively. (B&#x02013;D) Carbon atoms are shown in green (D1) or orange (&#x003c3;1H), oxygen atoms in red, and nitrogen atoms in blue. Dotted lines represent hydrogen bonds and salt bridges. For clarity, only interacting residues are shown. Amino acids are labeled in single-letter code. (B) Interactions between D1 and residues in the 3<sub>10</sub> helix in the D&#x02013;E loop of &#x003c3;1H. The 3<sub>10</sub> helix is depicted transparently so that the main chain interactions are visible. (C) Additional interactions between D1 and &#x003c3;1H around the region depicted in B. (D) Interactions between the F&#x02013;G and B&#x02013;C loops of D1 with &#x003c3;1H.</p></caption><graphic xlink:href="ppat.1000235.g002"/></fig><fig id="ppat-1000235-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g003</object-id><label>Figure 3</label><caption><title>Composite annealed omit map of a &#x003c3;1H-D1 contact area.</title><p>2F<sub>obs</sub>-F<sub>calc</sub> composite annealed omit map, calculated with CNS <xref ref-type="bibr" rid="ppat.1000235-Brnger1">&#x0005b;56&#x0005d;</xref>, contoured at 1&#x003c3; and shown in stereo. The map depicts key residues and their interactions at the complex interface. Carbon atoms of D1 and &#x003c3;1H are shown in green and orange, respectively. Oxygen atoms are shown in red and nitrogen atoms in blue. Amino acids are labeled in single-letter code.</p></caption><graphic xlink:href="ppat.1000235.g003"/></fig><p>The upper, larger &#x003c3;1H jaw contacts the D1 interdomain interface. Contacts are largely polar, featuring numerous hydrogen bonds and two salt bridges. These interactions are centered at the &#x003c3;1H 3<sub>10</sub> helix, in which residues Thr380, Gly381, and Asp382 interact with D1 residues Glu61, Asn76, and Arg59, respectively (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2B</xref>). These contacts are augmented by interactions between &#x003c3;1H D&#x02013;E loop residues Val371 and Glu384 and D1 residues Asn76, Lys78, and Lys63, and by contacts between Asp423 in the F&#x02013;G loop of &#x003c3;1H and the main-chain nitrogen atom of Ala81 (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2C</xref>). In addition to these polar interactions, D1 residues Leu72 and Tyr75 engage in hydrophobic contacts with D&#x02013;E loop residues and the terminal part of &#x003b2;-strand F in &#x003c3;1H (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2C</xref>). Previous point mutagenesis studies indicate that D1 residues Arg59, Glu61, Lys63, Leu72, Tyr75, and Asn76 contribute to &#x003c3;1 binding <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. Interestingly, most of the D1 residues engaged in interactions with &#x003c3;1H form contacts of a similar nature in the JAM-A homodimer. For example, D1 residue Arg59 forms a salt bridge with Asp382 in the complex and a salt bridge with D1 residue Glu61 in the JAM-A dimer. Similarly, Leu72 and Tyr75, which mediate hydrophobic contacts in the complex, also do so in the JAM-A dimer.</p><p>Contacts mediated by the smaller, lower jaw of &#x003c3;1H lack hydrogen bonds and salt bridges. Instead, extensive hydrophobic interactions with substantial surface complementarity are found, indicating that this area also plays an important role in defining specificity and providing high affinity. In &#x003c3;1H, interactions involve &#x003b2;-spiral residue Tyr298, a mostly hydrophobic surface of the &#x003b1;-helix connecting the &#x003b2;-spiral with the &#x003b2;-barrel, the non-polar portion of the Arg316 side chain, and Pro377 in the D&#x02013;E loop (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2D</xref>). These residues surround the D1 F&#x02013;G loop, which contains several partially hydrophobic residues. The nearby B&#x02013;C loop of D1 also faces towards the &#x003c3;1H &#x003b2;-spiral, with its closest contact between the hydroxyl group of D1 residue Ser57 and the tip of the &#x003b2;-spiral in &#x003c3;1H. Ser57 also contributes to &#x003c3;1 binding <xref ref-type="bibr" rid="ppat.1000235-Forrest1">&#x0005b;26&#x0005d;</xref>.</p><p>The majority of interactions between &#x003c3;1H and D1 involve hydrophilic residues, with a surprisingly large number of charged residues participating in contact formation. Three charged &#x003c3;1H residues directly mediate polar interactions with D1, and two others do so indirectly. In D1, four direct contacts are formed with charged residues. As a result, the interacting surfaces of both &#x003c3;1H and D1 display strong electrostatic potentials (<xref ref-type="fig" rid="ppat-1000235-g004">Figure 4A</xref>). When comparing the two, the interacting surface of &#x003c3;1H has a dominant electronegative potential in the upper jaw, whereas the lower jaw is electropositive. The interacting surface of D1 is complementary to &#x003c3;1H, featuring an electropositive potential at the dimer interface and a more electronegative potential at the most membrane-distal part of the domain. The importance of charged residues in the interaction between &#x003c3;1 and JAM-A is highlighted by the observation that the complex dissociates at pH values lower than 5 (<xref ref-type="fig" rid="ppat-1000235-g004">Figure 4B</xref>).</p><fig id="ppat-1000235-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g004</object-id><label>Figure 4</label><caption><title>Electrostatic potentials and complex stability at low pH.</title><p>(A) Electrostatic potential of the surfaces of D1 (left) and a single &#x003c3;1H subunit (right) calculated with APBS tools <xref ref-type="bibr" rid="ppat.1000235-Lerner1">&#x0005b;64&#x0005d;</xref>. The scale ranges from &#x02212;3 (red) to &#x0002b;3 (blue) in units of k<sub>B</sub>T/e<sub>c</sub>. Boundaries of the contact areas of the complex are outlined in black. The other two &#x003c3;1H monomers are shown as yellow ribbons. (B) Size-exclusion chromatographs of the &#x003c3;1H-D1 complex using conditions of varied pH. The &#x003c3;1H, wt D1, and monomeric D1 E121A proteins were used as controls to determine whether a shift in elution volume was attributable to disassociation of the complex into its components or pH-dependent alteration of protein elution behavior. Glu121 in the D1 dimer interface does not participate in complex formation with &#x003c3;1H. Thus, its alteration affects JAM-A dimerization but not &#x003c3;1H ligation <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. The &#x003c3;1H-D1 complex was stable at pH values 7.4 and 5.0, eluting from the column earlier than &#x003c3;1H, wt D1, and D1 E121A. However, at pH values 4.5 or 4.0, the complex dissociated into its components, which eluted at the same volumes as the controls, &#x003c3;1H and D1. Similarly, wt D1 dissociated under conditions of low pH, eluting at the same volume as the monomeric mutant D1 E121A. This result is in agreement with data obtained in previous studies of the murine JAM-A dimer <xref ref-type="bibr" rid="ppat.1000235-Bazzoni1">&#x0005b;30&#x0005d;</xref>. At pH 4.5 and 4.0, the A<sub>280</sub> of &#x003c3;1H was multiplied by 10 to compensate for the lower concentration due to precipitation.</p></caption><graphic xlink:href="ppat.1000235.g004"/></fig></sec><sec id="s2d"><title>Stability of the JAM-A Homodimer</title><p>The &#x003c3;1H-D1 complex is readily produced in solution by mixing the two components. Although JAM-A dissociates under high salt or low pH conditions <xref ref-type="bibr" rid="ppat.1000235-Bazzoni1">&#x0005b;30&#x0005d;</xref>, we were not able to detect monomeric species of JAM-A in the neutral pH, low salt conditions used for complex formation (data not shown). Thus, we conclude that complex formation requires disruption of JAM-A homodimers by &#x003c3;1. This process could be facilitated by a significantly higher affinity between &#x003c3;1 and JAM-A D1 compared to that of the homophilic JAM-A interaction. The dissociation constant (K<sub>D</sub>) for the &#x003c3;1-JAM-A complex is in the low nanomolar range <xref ref-type="bibr" rid="ppat.1000235-Barton1">&#x0005b;4&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. To determine a K<sub>D</sub> value for the JAM-A D1 homodimer, we performed analytical ultracentrifugation experiments at near-physiological conditions (Tris pH 7.5, 100 mM NaCl). Five JAM-A D1 samples at concentrations ranging from 0.06 to 1.31 mg/mL were used for the sedimentation velocity experiments. Sedimentation velocities showed little concentration dependence of the sedimentation coefficient (<xref ref-type="supplementary-material" rid="ppat.1000235.s002">Figure S2A</xref>). The main component sediments at &#x0223c;2.35 S. This value corresponds to molar masses between 19 kg/mol and 22 kg/mol, close to that expected for dimeric JAM-A D1. We also detected significant but variable amounts of a second component, sedimenting at 3.8 S. This species is most likely tetrameric JAM-A D1. While tetramers of JAM-A in solution have been observed <xref ref-type="bibr" rid="ppat.1000235-Bazzoni1">&#x0005b;30&#x0005d;</xref>, our analytical ultracentrifugation experiments did not reveal a tendency of JAM-A to form tetramers in a concentration-dependent manner, suggesting that this species is not physiologic.</p><p>Sedimentation equilibrium experiments were conducted at four different concentrations (0.16 to 1.6 mg/mL) at three different speeds. The best fit (r.m.s.d. of 1.99&#x000d7;10<sup>&#x02212;2</sup> with 5109 degrees of freedom) for all available data sets was for a monomer-dimer model with variable amounts of tetramer (<xref ref-type="supplementary-material" rid="ppat.1000235.s002">Figure S2B</xref>). The molar mass converged to a value of 10.94 kg/mol (10.90 to 11.16 kg/mol), which is very close to the expected molar mass for monomeric JAM-A D1 (11.5 kg/mol). The K<sub>D</sub> for this fit is 1.1&#x000d7;10<sup>&#x02212;5</sup> M (0.8 to 1.4&#x000d7;10<sup>&#x02212;5</sup> M). If the molar mass is constrained to the expected value, a poorer fit (r.m.s.d. error of 2.19&#x000d7;10<sup>&#x02212;2</sup>, 5110 degrees of freedom) is obtained. The slight mismatch between the best-fit and the expected molar mass indicates an imprecision in the calculation of the partial specific volume or density of the buffer.</p></sec><sec id="s2e"><title>Contribution of Individual &#x003c3;1 Residues to JAM-A Engagement and Infectivity</title><p>To identify contributions of individual residues in &#x003c3;1 to JAM-A engagement, we employed plasmid-based reverse genetics <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref> to engineer mutations into the &#x003c3;1 protein of reovirus strain T3D. Mutant viruses were isolated following co-transfection of murine L929 (L) cells with nine RNA-encoding plasmids corresponding to wt T3D genes and a tenth plasmid corresponding to the &#x003c3;1-encoding <italic>S1</italic> gene incorporating site-specific mutations. Thus, each resultant virus is isogenic, with the exception of the <italic>S1</italic> gene and its protein product, &#x003c3;1. Guided by the structure of the &#x003c3;1H-D1 complex, we engineered individual substitutions of Thr380, Gly381, and Glu384 in the D&#x02013;E loop and Asp423 in the F&#x02013;G loop of the JAM-A-binding region of &#x003c3;1. In addition, we also mutated Asn369, which is located at the N-terminus of the D&#x02013;E loop, but does not contact JAM-A. With the exception of Asp423, these residues are conserved in sequence alignments among prototype strains from all three reovirus serotypes <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>. All mutant viruses were recovered and produced sufficient titer to allow binding and infectivity studies.</p><p>To determine effects of substitutions in the JAM-A-binding region of &#x003c3;1 on viral infectivity, we adsorbed HeLa cells with the parent or mutant viruses at a multiplicity of infection (MOI) of 50 plaque-forming units (PFU) per cell and quantified infected cells in confluent fields of view following 20 h of incubation. With the exception of E384A, each of the point-mutant viruses exhibited significantly diminished infectivity in comparison to the parent strain, with the G381A mutant infecting the fewest cells (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5A</xref>). T3 reoviruses bind to sialic acid, an event mediated by sequences in the &#x003c3;1 tail <xref ref-type="bibr" rid="ppat.1000235-Chappell1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Barton2">&#x0005b;31&#x0005d;</xref>, which enhances attachment and infectivity in HeLa cells <xref ref-type="bibr" rid="ppat.1000235-Chappell1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Barton2">&#x0005b;31&#x0005d;</xref>. Therefore, the parent and &#x003c3;1 point-mutant viruses should retain the capacity to bind sialic acid. To determine effects on viral infectivity of mutated residues in the JAM-A-binding surface of &#x003c3;1 in the absence of sialic acid binding, we pre-treated HeLa cells with <italic>A. ureafaciens</italic> neuraminidase to remove sialic acid prior to viral adsorption (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5A</xref>). As expected, neuraminidase-treatment resulted in decreased infectivity for all viruses, with &#x0223c;60&#x00025; fewer infected cells for the parent virus. In comparison to the parent strain, the T380A, G381A, and D423A viruses exhibited a significant decrease in viral infectivity in the absence of sialic acid. The relative decrease in infectivity of N369A compared to the parent virus following neuraminidase treatment was less than that observed in untreated cells. The explanation for this result is not clear, but it may be due to some type of cooperative interaction between the &#x003c3;1 receptor-binding domains unmasked by the N369A mutant. We conclude that targeted mutations in the JAM-A-binding surface of &#x003c3;1 influence viral infectivity, presumably due to altered viral avidity for JAM-A.</p><fig id="ppat-1000235-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g005</object-id><label>Figure 5</label><caption><title>Identification of &#x003c3;1 residues required for infection of cultured cells and JAM-A binding.</title><p>(A) Infection of HeLa cells by parent or mutant virus. Cells were treated with either PBS alone (mock) or 40 mU/ml of neuraminidase diluted in PBS (NA). Infected cells were identified by indirect immunofluorescence and quantified in three fields of view. The results are expressed as the mean fluorescent focus units (FFU) per field for triplicate experiments. Error bars indicate standard deviations. The asterisk indicates <italic>P</italic>&#x0003c;0.05 in comparison to the control. (B) SPR analysis of reovirus binding to JAM-A. Traces show binding and dissociation from GST-JAM-A for purified reoviruses at a concentration of 6&#x000d7;10<sup>12</sup> (green), 8&#x000d7;10<sup>12</sup> (orange), and 10<sup>13</sup> (red) particles/ml. Reovirus binding to the capturing molecule (grey) is set as the baseline. Binding is expressed in resonance units (RU).</p></caption><graphic xlink:href="ppat.1000235.g005"/></fig><p>To determine the JAM-A-binding capacity of the mutant viruses, we captured purified JAM-A, as an N-terminal fusion with GST, on a biosensor surface and employed surface plasmon resonance (SPR) to assess viral binding <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. Upon injection of the parent virus at 6&#x000d7;10<sup>12</sup>, 8&#x000d7;10<sup>12</sup>, and 1&#x000d7;10<sup>13</sup> particles/mL, we observed specific, concentration-dependent association with JAM-A over time (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5B</xref>). In accord with the infectivity results, all mutant viruses except E384A exhibited diminished binding in comparison to the parent strain, suggesting that these residues contribute significantly to interactions with JAM-A. Interestingly, the E384A mutant exhibited higher overall binding responses than the parent virus, suggesting this virus has enhanced avidity for JAM-A. However, this enhanced avidity does not appear to translate into enhanced infectivity in HeLa cells (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5A</xref>).</p></sec></sec><sec id="s3"><title>Discussion</title><p>The interaction between reovirus &#x003c3;1 and JAM-A is the first step in an infectious cycle that culminates in the death of the target cell. While some reovirus strains use additional co-receptors, all strains engage JAM-A <xref ref-type="bibr" rid="ppat.1000235-Campbell1">&#x0005b;32&#x0005d;</xref>. JAM-A exists as a dimer in solution <xref ref-type="bibr" rid="ppat.1000235-Bazzoni1">&#x0005b;30&#x0005d;</xref> and most likely at the cell surface, but monomers are bound by &#x003c3;1 in our crystal structure. The binding studies we report here show that formation of the &#x003c3;1-JAM-A complex is clearly preferred to the formation of JAM-A homodimers. The interaction between two JAM-A molecules has a K<sub>D</sub> of 1.1&#x000d7;10<sup>&#x02212;5</sup> M, whereas the K<sub>D</sub> for the &#x003c3;1-JAM-A interaction is about 1,000-fold lower <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. These differences in affinity are remarkable given that the surfaces buried in the two complexes are strikingly similar in shape, almost identical in size, and share many of the same residues (<xref ref-type="fig" rid="ppat-1000235-g006">Figure 6A and 6B</xref>). Why might JAM-A have a higher affinity for &#x003c3;1 than for JAM-A? The structure of the JAM-A dimer <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> reveals a cavity in the dimer interface of about 6.9 &#x000c5;<sup>3</sup> in size (<xref ref-type="fig" rid="ppat-1000235-g006">Figure 6C</xref>) (calculated using VOIDOO <xref ref-type="bibr" rid="ppat.1000235-Kleywegt1">&#x0005b;33&#x0005d;</xref>). In contrast, no cavities are found in the six copies of the &#x003c3;1-JAM-A complex interfaces, which feature nearly perfect surface complementarity. Cavities in protein-protein interfaces usually contain water molecules that can significantly destabilize hydrogen bonds and salt bridges by lowering the dielectric constant of the medium. Indeed, two water molecules are visible in the cavity of the JAM-A dimer interface, and two more are adjacent to this surface <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>. The presence of water at the center of the JAM-A dimer interface could thus weaken the homophilic interaction. Concordantly, the JAM-A dimer interface is dynamic, which is thought to facilitate transitions between monomeric and dimeric forms <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>. The transitional nature of the homophilic JAM-A interaction may play a role in the regulation of tight junction permeability. A similar cavity is found in the crystal structure of murine JAM-A <xref ref-type="bibr" rid="ppat.1000235-Kostrewa1">&#x0005b;23&#x0005d;</xref>, which also can bind &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Barton1">&#x0005b;4&#x0005d;</xref>.</p><fig id="ppat-1000235-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g006</object-id><label>Figure 6</label><caption><title>Comparison of the JAM-A D1 dimer and the &#x003c3;1H-D1 complex.</title><p>(A) Surface representations of D1, with key contact residues (residues forming hydrogen bonds, salt bridges, or close hydrophobic contacts) highlighted in orange (&#x003c3;1H-D1 complex, top) or green (D1 dimer, bottom). Additional contacts are not shown. (B) Ribbon drawings of D1 showing stick representations of the same contacts depicted in (A). Carbon atoms are shown in orange (&#x003c3;1H-D1 complex, left) or green (JAM-A dimer, right), oxygen atoms in red, nitrogen atoms in blue, and sulfur atoms in yellow. Amino acids are labeled in single-letter code. (C) Cavity at the JAM-A homodimer interface. The JAM-A homodimer <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> is viewed along the two-fold axis and depicted in stick representation (green and yellow). The protein surface is shown in a semitransparent white rendering. The JAM-A D1 domain is opened at the center to reveal the cavity, calculated using VOIDOO <xref ref-type="bibr" rid="ppat.1000235-Kleywegt1">&#x0005b;33&#x0005d;</xref>, which is shown as a red mesh.</p></caption><graphic xlink:href="ppat.1000235.g006"/></fig><p>Our results indicate that several residues in the &#x003c3;1 D&#x02013;E loop are especially important for efficient JAM-A engagement. Mutation of Asn369, Thr380, Gly381, or Asp423 to alanine leads to drastically impaired JAM-A binding on a biosensor surface and reduced infectivity of HeLa cells (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5</xref>). These results can now be rationalized by the structure of the complex. Mutation of Gly381 would adversely affect interactions with JAM-A, as any side chain at this position would lead to steric clashes with D1 residue Tyr75. The Thr380 side chain likely shields hydrophobic interactions from solvent (<xref ref-type="fig" rid="ppat-1000235-g002">Figure 2C</xref>). Moreover, since Thr380 makes extensive contacts with other &#x003c3;1 residues, truncation of its side chain would likely affect the structural integrity of the 3<sub>10</sub> helix and thus diminish JAM-A binding. Changes in local structure also might explain the reduced binding observed for the N369A mutant. Although Asn369 does not directly contact D1, its location at the N-terminus of the D&#x02013;E loop may help to stabilize the 3<sub>10</sub> helix. Asp423 interacts with the main chain amide group of Ala81 in JAM-A and, like Thr380, shields hydrophobic interactions from solvent. Interestingly, the E384A mutant exhibits slightly enhanced binding to JAM-A. The Glu384 side chain interacts with nearby &#x003c3;1 residues His388 and Trp421 and may stabilize this region, which probably includes several water molecules bound to surrounding side chains. These interactions are likely altered to allow &#x003c3;1 to bind JAM-A. We think it possible that truncation of the Glu384 side chain would facilitate this process.</p><p>To visualize how &#x003c3;1 interacts with JAM-A at the cell surface, we combined the structures of the &#x003c3;1H-D1 complex, the JAM-A extracellular domain <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>, and the C-terminus of &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref> with a model of the N-terminus of &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Guglielmi2">&#x0005b;34&#x0005d;</xref>, as previously done to generate a model of adenovirus fiber binding to CAR <xref ref-type="bibr" rid="ppat.1000235-Wu1">&#x0005b;35&#x0005d;</xref> (<xref ref-type="fig" rid="ppat-1000235-g007">Figure 7</xref>). The model was produced by superimposing JAM-A <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> and a full-length model of &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref> onto the &#x003c3;1H-D1 complex structure. Based on the positioning of &#x003c3;1 and JAM-A in the model, JAM-A must reach beyond the approaching &#x003c3;1 head to access residues in the C-terminal region of the &#x003c3;1 tail. Residues in the predicted &#x003b2;-spiral repeat region of the &#x003c3;1 tail, closer to the midpoint of the &#x003c3;1 molecule, are required for engagement of carbohydrate <xref ref-type="bibr" rid="ppat.1000235-Chappell2">&#x0005b;12&#x0005d;</xref>. Thus, the processes of JAM-A and carbohydrate engagement are likely facilitated by regions of flexibility within both the receptor and the viral attachment protein <xref ref-type="bibr" rid="ppat.1000235-Fraser1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Furlong1">&#x0005b;9&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>. Since the binding sites for JAM-A are distinct from each other in the &#x003c3;1 trimer, and since D1 projects from the cell surface, it is conceivable that each &#x003c3;1 trimer simultaneously engages more than one JAM-A monomer. This scenario assumes that both monomers in the JAM-A dimer are located on the same cell. Binding of &#x003c3;1 would lead to separation of JAM-A dimers into monomers, both of which likely remain in close proximity and could engage the same &#x003c3;1 trimer. In this fashion, several molecules of JAM-A could form a clamp that engages &#x003c3;1 and tightly adheres the virus to the cell, as depicted in our model.</p><fig id="ppat-1000235-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000235.g007</object-id><label>Figure 7</label><caption><title>Full-length model of the &#x003c3;1-JAM-A complex.</title><p>A model of full-length &#x003c3;1 extending from a schematic representation of a virion is shown as a ribbon drawing, with the known structure of the C-terminus <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref> in tricolor and the predicted structure of the N-terminus in grey. A model of full-length JAM-A is shown in green as a ribbon drawing of the known structure of the extracellular domain <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> and a schematic representation of the transmembrane (TM) and intracellular domains. Arrows indicate regions of flexibility. For clarity, only two JAM-A monomers are shown bound to &#x003c3;1.</p></caption><graphic xlink:href="ppat.1000235.g007"/></fig><p>Although the &#x003c3;1 sequence is the most divergent among the reovirus proteins, prototype and field-isolate strains of the three most prevalent reovirus serotypes use JAM-A as a receptor <xref ref-type="bibr" rid="ppat.1000235-Campbell1">&#x0005b;32&#x0005d;</xref>. Based on sequence alignment, the highest degree of conservation is observed among residues in the D&#x02013;E loop, suggesting that this region forms part of the JAM-A-binding site <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Campbell1">&#x0005b;32&#x0005d;</xref>. However, several T3D &#x003c3;1 residues that interact with JAM-A are not conserved in prototype strains type 1 Lang (T1L) and type 2 Jones (T2J) &#x003c3;1 <xref ref-type="bibr" rid="ppat.1000235-Chappell3">&#x0005b;14&#x0005d;</xref>. For example, reovirus T2J possesses an alanine rather than an aspartate residue at position 423. We found that a mutant reovirus containing a D423A polymorphism exhibits reduced binding to JAM-A and diminished infectivity in HeLa cells in comparison to the parent virus (<xref ref-type="fig" rid="ppat-1000235-g005">Figure 5A</xref>). These observations suggest that, while the binding sites may be similar, &#x003c3;1-JAM-A interactions may differ at an atomic level among the reovirus serotypes. Serotype-specific differences such as the D423A polymorphism may in turn alter the affinity of &#x003c3;1 proteins for JAM-A and thus influence reovirus tropism <italic>in vivo</italic>.</p><p>Structural analyses have revealed striking similarities between reovirus &#x003c3;1 and adenovirus fiber and their respective receptors, JAM-A and CAR, pointing to an evolutionary relationship in the attachment strategies used by these viruses <xref ref-type="bibr" rid="ppat.1000235-Stehle1">&#x0005b;36&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Stehle2">&#x0005b;37&#x0005d;</xref>. A comparison of the &#x003c3;1-JAM-A complex with that of the adenovirus type 12 (Ad12) fiber knob in complex with the D1 domain of human CAR <xref ref-type="bibr" rid="ppat.1000235-Bewley1">&#x0005b;38&#x0005d;</xref> reveals conserved features, providing additional support for common ancestry among the two viruses. Both attachment proteins form trimers that bind three copies of the D1 domain of the receptor. Like JAM-A, CAR uses the dimer interface and the top (B&#x02013;C and F&#x02013;G loops) to engage its viral ligand. Also like JAM-A, fiber-contacting residues of CAR are mainly located in and adjacent to &#x003b2;-strands C, C&#x02032;, C&#x02033;, F, and G. Moreover, the thermodynamic properties of both interactions are remarkably similar. The K<sub>D</sub> for the fiber-CAR complex is in the nanomolar range (0.5 to 1.5&#x000d7;10<sup>&#x02212;8</sup> M for Ad5 fiber <xref ref-type="bibr" rid="ppat.1000235-Kirby1">&#x0005b;39&#x0005d;</xref>), which also is about 1,000-fold lower than the K<sub>D</sub> of homodimeric CAR interactions (1.6&#x000d7;10<sup>&#x02212;5</sup> M <xref ref-type="bibr" rid="ppat.1000235-vanRaaij2">&#x0005b;25&#x0005d;</xref>). However, unlike &#x003c3;1, which uses sequences in the head and tail to bind JAM-A, the CAR-binding area in Ad12 fiber is located entirely in the knob and does not include residues in the shaft. In contrast to the &#x003c3;1-JAM-A complex, in which one JAM-A D1 domain exclusively contacts one &#x003c3;1 monomer, CAR also has some contacts with a second subunit in the fiber knob. Thus, the two virus-receptor complexes are similar in the contact areas formed by the receptors and the thermodynamic forces that contribute to complex formation, but the viral attachment proteins engage the receptors using different binding sites. Viruses in addition to adenovirus and reovirus engage CAR and JAM-A, respectively. Coxsackievirus binds CAR <xref ref-type="bibr" rid="ppat.1000235-Bergelson1">&#x0005b;40&#x0005d;</xref>, and feline calicivirus binds fJAM-1, the feline homologue of JAM-A <xref ref-type="bibr" rid="ppat.1000235-Makino1">&#x0005b;5&#x0005d;</xref>. Both coxsackievirus and feline calicivirus, which are spherical nonenveloped viruses, require the D1 and D2 domains of their respective receptors for binding <xref ref-type="bibr" rid="ppat.1000235-He1">&#x0005b;41&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Ossiboff1">&#x0005b;42&#x0005d;</xref>. The cryo-EM structure of feline calicivirus in complex with fJAM-1 shows that the virus binds both domains of fJAM-1 with more contacts located in the D1 domain <xref ref-type="bibr" rid="ppat.1000235-Bhella1">&#x0005b;43&#x0005d;</xref>. Interestingly, the cryo-EM structure of coxsackievirus in complex with CAR shows that only the distal end of the D1 domain binds to the virus, but formation of complexes appears to require both CAR D1 and D2 <xref ref-type="bibr" rid="ppat.1000235-He1">&#x0005b;41&#x0005d;</xref>.</p><p>The capacity to redirect viral vectors to specific target cells by modification of receptor-binding capacity provides a powerful approach for delivery of an engineered viral payload to an appropriate site. For example, retargeting adenovirus from cells expressing CAR to cells expressing JAM-A has been accomplished using a chimeric adenovirus that expresses reovirus &#x003c3;1 in place of adenovirus fiber <xref ref-type="bibr" rid="ppat.1000235-Mercier1">&#x0005b;44&#x0005d;</xref>. Development of plasmid-based reverse genetics for reovirus <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref>, coupled with the oncolytic potential of this virus <xref ref-type="bibr" rid="ppat.1000235-Forsyth1">&#x0005b;45&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000235-Wilcox1">&#x0005b;49&#x0005d;</xref>, underscores the importance of a precise understanding of &#x003c3;1 interactions with cellular receptors. Here, we provide proof-of-principle that reovirus mutants with structure-guided alterations in receptor-binding capacity can be engineered. This achievement represents a first step towards designing viruses containing modified &#x003c3;1 proteins to target specific sites in the host based on receptor utilization.</p><p>The majority of known three-dimensional structures of viral proteins in complex with protein receptors involve molecules of the IgSF type. In addition to the complex presented here, such receptors are components of the HIV gp120-CD4 <xref ref-type="bibr" rid="ppat.1000235-Kwong1">&#x0005b;50&#x0005d;</xref>, rhinovirus-ICAM-1 <xref ref-type="bibr" rid="ppat.1000235-Bella1">&#x0005b;51&#x0005d;</xref>, and adenovirus-CAR <xref ref-type="bibr" rid="ppat.1000235-Bewley1">&#x0005b;38&#x0005d;</xref> complexes. In each case, the receptors exist as homodimers in solution <xref ref-type="bibr" rid="ppat.1000235-vanRaaij2">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Miller1">&#x0005b;52&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Wu2">&#x0005b;53&#x0005d;</xref> but are engaged as monomers by their viral ligands. For JAM-A and CAR, and possibly also for CD4 and ICAM-1, engagement by viruses is incompatible with the existence of a homodimer. Whether disruption of dimers alters cellular functions of these receptors is currently unclear. Although not an IgSF receptor, the recent crystal structure of ephrin-B2 bound to the Nipah virus G glycoprotein also shows that G engages an ephrin-B2 surface that normally interacts with the receptor Eph <xref ref-type="bibr" rid="ppat.1000235-Bowden1">&#x0005b;54&#x0005d;</xref>. The &#x003c3;1-JAM-A structure presented here may therefore reveal an ancient mechanism by which viruses usurp existing receptor interfaces and cleverly engage them in an energetically more favorable manner.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Protein Expression, Purification, and Complex Formation</title><p>Sequences corresponding to residues 28&#x02013;129 of hJAM-A D1 (UniProtKB/Swiss-Prot entry Q9Y624) were amplified from a plasmid encoding full-length JAM-A <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> and cloned as an N-terminal GST-fusion into pGEX-4T-3 (GE Healthcare) using BamHI-XhoI restriction sites. The D1 E121A mutant was engineered from this construct <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>. JAM-A D1 and the T3D &#x003c3;1 head domain (&#x003c3;1H; residues 293&#x02013;455; UniProtKB/Swiss-Prot entry P03528) were purified as described <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref>, with minor modifications. Expression of the GST-D1 fusion proteins was induced in 1 L Luria Broth (Sigma-Aldrich) with 0.2 mM IPTG in <italic>Escherichia coli</italic> strain BL21 (DE3) pLysS (Novagen) at 25&#x000b0;C for 16 h. Bacteria were harvested by centrifugation, resuspended in 50 mM Tris &#x0005b;pH 7.5&#x0005d;, 50 mM NaCl, 3 mM EDTA, 1&#x00025; Triton X-100, 2 mM &#x003b2;-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and 100 &#x000b5;g/mL lysozyme, sonicated with 50&#x00025; duty-cycle using a Branson Digital Sonifier 250, and centrifuged at 15,000&#x000d7;<italic>g</italic>. The clarified supernatant was passed over a 5 mL GSTrapFF column (GE Healthcare), which was washed with buffer (50 mM Tris &#x0005b;pH 7.5&#x0005d;, 3 mM EDTA), ATP-Mg<sup>2&#x0002b;</sup>-buffer (20 mM MgSO<sub>4</sub> and 10 mM ATP in buffer), and high-salt buffer (1 M NaCl in buffer). D1 was cleaved from GST on-column by overnight incubation with 150 units of thrombin (GE Healthcare) in 20 mM Tris &#x0005b;pH 7.8&#x0005d;, 2.5 mM CaCl<sub>2</sub>, 150 mM NaCl. Induction of the &#x003c3;1H construct was achieved using 0.4 mM IPTG, and bacteria were lysed using a high-pressure homogenizer (Avestin EmulsiFlex). After removal of GST, the sequence of each protein was identical to the native sequence with the exception of two amino acids at the N-terminus: Gly291 and Ser292 for &#x003c3;1H and Gly26 and Ser27 for D1. None of these amino acids contribute to complex formation. Purified &#x003c3;1H and D1 were mixed at a ratio of 1&#x02236;1.2 and incubated at 4&#x000b0;C for 30 min. Complexes were separated from excess D1 by size-exclusion chromatography in 20 mM Tris &#x0005b;pH 7.5&#x0005d;, 100 mM NaCl using a Superdex 75 column (GE Healthcare). Analytical-scale size-exclusion chromatography to assay complex stability was performed using a SMART system (GE Healthcare) with a Superdex 75 PC 3.2/30 column.</p></sec><sec id="s4b"><title>Crystallization and Structure Determination</title><p>The &#x003c3;1H-D1 complex was concentrated to 4 mg/mL according to direct measurement of A<sub>280</sub> and A<sub>260</sub> (c&#x0005b;mg/mL&#x0005d;&#x0200a;&#x0003d;&#x0200a;1.55&#x000d7;A<sub>280</sub>&#x02212;0.76&#x000d7;A<sub>260</sub>). Crystals were initially obtained by mixing equal volumes of protein and 0.1 M CHES &#x0005b;pH 9.5&#x0005d;, 30&#x00025; polyethylene glycol 3000 (Wizard I Screen, Emerald BioSystems) at 20&#x000b0;C. Larger crystals were grown upon replacement of polyethylene glycol 3000 with polyethylene glycol 3350 and with streak seeding using cat whiskers (collected after natural loss). Crystals were flash-frozen with 20&#x00025; glycerol as cryoprotectant. Data were collected at the X06SA beamline of the Swiss Light Source (Villigen, Switzerland) at 100 K and a wavelength of 0.92 &#x000c5; using a MarCCD detector. The crystals were extremely thin. They had to be exposed for 10 seconds to an unattenuated beam to yield any diffraction beyond 4.0 &#x000c5; and suffered severe radiation damage after only brief exposure. A total of 286 images from several dozen crystals were collected, and 85 of those were used to assemble the final data set. Since the radiation damage led to dramatic decreases in spot intensity for many reflections at higher resolution, we evaluated all processed data files with an in-house program, calculating the signal-to-noise ratio (<italic>I/&#x003c3;I</italic>) according to resolution bins for each frame in order to apply individual resolution cut-offs. This procedure significantly improved the overall quality of the data set.</p><p>Data were integrated and reduced with HKL (HKL Research). Crystals belong to the orthorhombic space group P2<sub>1</sub>2<sub>1</sub>2 (a&#x0200a;&#x0003d;&#x0200a;105.9 &#x000c5;, b&#x0200a;&#x0003d;&#x0200a;124.3 &#x000c5;, c&#x0200a;&#x0003d;&#x0200a;130.6 &#x000c5;). The asymmetric unit consists of two &#x003c3;1H trimers, each complexed with three D1 monomers. Initial phases were obtained by molecular replacement with PHASER in CCP4 <xref ref-type="bibr" rid="ppat.1000235-CCP41">&#x0005b;55&#x0005d;</xref> using the trimeric T3D &#x003c3;1H structure (PDB ID 2OJ5) <xref ref-type="bibr" rid="ppat.1000235-Schelling1">&#x0005b;13&#x0005d;</xref> as a search model. Molecular replacement solutions for two &#x003c3;1H trimers in the asymmetric unit were readily obtained and resulted in an overall <italic>R</italic>-factor of 40.1&#x00025; (30&#x02013;3.4 &#x000c5;). Initial attempts to locate the D1 domains of hJAM-A (PDB ID 1NBQ) <xref ref-type="bibr" rid="ppat.1000235-Prota1">&#x0005b;24&#x0005d;</xref> by molecular replacement were not successful. However, 2F<sub>obs</sub>-F<sub>calc</sub> and F<sub>obs</sub>-F<sub>calc</sub> electron-density maps, calculated using phases obtained from the two &#x003c3;1H trimers, which account for 61&#x00025; of the protein atoms present in the crystal, clearly revealed the position and location of the six D1 domains. Adding the D1 domains to the structure reduced the overall <italic>R</italic>-factor to 34.7&#x00025; (30&#x02013;3.4 &#x000c5;) before refinement.</p><p>The structure was refined using CNS <xref ref-type="bibr" rid="ppat.1000235-Brnger1">&#x0005b;56&#x0005d;</xref> and Coot <xref ref-type="bibr" rid="ppat.1000235-Emsley1">&#x0005b;57&#x0005d;</xref>. Refinement was performed using rigid body refinement, simulated annealing, restrained individual B-factor refinement, and conjugate gradient minimization. B-factors were refined individually because unrestrained group B-factor refinement was unstable. No sigma-cut-off was used. For the NCS restraints, we defined two groups of restrained coordinates. NCS group one contained all six copies of &#x003c3;1, and NCS group two contained six copies of JAM-A D1. Thus, we did not restrain the complexes, but we did restrain the individual components, taking into account the partially dislodged D1 molecules (see <xref ref-type="sec" rid="s2">results</xref> section). In all cases, loops that participate in crystal contacts and did not have the same structures in all copies were omitted from the restraining procedure. Electron-density maps were improved using non-crystallographic symmetry averaging <xref ref-type="bibr" rid="ppat.1000235-Kleywegt2">&#x0005b;58&#x0005d;</xref> and data sharpening <xref ref-type="bibr" rid="ppat.1000235-Gamblin1">&#x0005b;59&#x0005d;</xref> by adding an overall B-factor of &#x02212;70 &#x000c5;<sup>2</sup> to the observed structure factors with CAD <xref ref-type="bibr" rid="ppat.1000235-CCP41">&#x0005b;55&#x0005d;</xref>. Data sharpening improved some details in the electron density map and allowed us to resolve a number of side chains that had poor electron density prior to sharpening. However, the unsharpened map was traceable. Contact areas were calculated using AREAIMOL <xref ref-type="bibr" rid="ppat.1000235-CCP41">&#x0005b;55&#x0005d;</xref>. Coordinates and structure factors have been deposited with the Protein Data Bank with the accession code 3EOY. All structural figures were prepared using PyMOL <xref ref-type="bibr" rid="ppat.1000235-DeLano1">&#x0005b;60&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Size-Exclusion Chromatographic Analysis of Complex Stability</title><p>The effect of pH on complex stability was investigated by concentrating purified &#x003c3;1H, wt D1, monomeric D1 E121A <xref ref-type="bibr" rid="ppat.1000235-Guglielmi1">&#x0005b;27&#x0005d;</xref>, and the &#x003c3;1H-D1 complex to 10&#x00025; of the original volume using Millipore 5,000 MWCO filters. Samples were diluted in 20 mM citrate buffers &#x0005b;pH 4.0, 4.5, or 5.0&#x0005d; or 20 mM Hepes &#x0005b;pH 7.4&#x0005d; and re-concentrated. This procedure was repeated five times. Size-exclusion chromatography was performed using the respective buffer for each sample, containing 100 mM NaCl.</p></sec><sec id="s4d"><title>Analytical Ultracentrifugation</title><p>For analytical ultracentrifugation experiments, JAM-A D1 was subjected to size-exclusion chromatography using a Superdex 75 column in 20 mM Tris &#x0005b;pH 7.5&#x0005d;, 100 mM NaCl. Sedimentation velocity and equilibrium experiments were performed at 25&#x000b0;C using a BeckmanCoulter (Krefeld, Germany) Xl-I analytical ultracentrifuge equipped with interference optics. The solvent density and partial specific volume of JAM-A D1 were calculated from composition using known density increments. Two-sector titanium centerpieces of 12 mm or 20 mm optical pathlengths (Nanolytics, Germany) were employed. A factor of 3.29 mg/mL/fringes was used to convert signal units into molar quantities. For sedimentation velocity experiments, 400 &#x000b5;L of protein solution at five concentrations between 0.06 and 1.31 mg/mL were centrifuged at 50 krpm. The concentration profiles were scanned every two minutes until all material had sedimented. Data were evaluated using the c(s)-function implemented in SedFit, version 9.4 <xref ref-type="bibr" rid="ppat.1000235-Schuck1">&#x0005b;61&#x0005d;</xref>. For sedimentation equilibrium experiments, four initial concentrations between 1.6&#x02013;0.16 mg/mL were prepared, and 150 &#x000b5;L of these solutions were centrifuged at three different velocities (17.5/25/35 krpm). Attainment of apparent sedimentation and chemical equilibrium was verified using MATCH. Equilibrium gradients were globally analyzed using NonLin (MATCH and NonLin are available at <ext-link ext-link-type="uri" xlink:href="http://www.biotech.uconn.edu/auf/?i=aufftp">http://www.biotech.uconn.edu/auf/?i=aufftp</ext-link>). Suitable models to describe the experimental data were selected based on minimized variance and visual inspection of the residuals run pattern. Different initial starting values for the floated parameters were used to confirm that the parameters were well defined by the data.</p></sec><sec id="s4e"><title>Cells, Viruses, and Antibodies</title><p>HeLa cells were propagated as described <xref ref-type="bibr" rid="ppat.1000235-Barton2">&#x0005b;31&#x0005d;</xref>. Reovirus strain rsT3D-&#x003c3;1T249I (parent) was engineered using plasmid-based reverse genetics <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref>. Reoviruses were purified by cesium chloride-gradient centrifugation from infected L cells <xref ref-type="bibr" rid="ppat.1000235-Furlong1">&#x0005b;9&#x0005d;</xref>. Particle concentrations were determined using the conversion factor 1 AU<sub>260</sub>&#x0200a;&#x0003d;&#x0200a;2.1&#x000d7;10<sup>12</sup> particles. Titers of virus stocks were determined by plaque assay using L cells <xref ref-type="bibr" rid="ppat.1000235-Virgin1">&#x0005b;62&#x0005d;</xref>. Attenuated vaccinia virus strain rDIs-T7pol expressing T7 RNA polymerase was propagated using chick embryo fibroblasts <xref ref-type="bibr" rid="ppat.1000235-Ishii1">&#x0005b;63&#x0005d;</xref>.</p></sec><sec id="s4f"><title>Plasmid-Based Reovirus Rescue</title><p>The parental <italic>S1</italic> gene used for these studies encodes a &#x003c3;1 molecule with a threonine to isoleucine substitution at position 249, which renders &#x003c3;1 resistant to proteolytic cleavage <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref>. Substitution mutations were engineered in pBacT7-S1T3D T249I <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref> using QuickChange site-directed mutagenesis (Stratagene). Reoviruses were recovered from plasmids as described <xref ref-type="bibr" rid="ppat.1000235-Kobayashi1">&#x0005b;7&#x0005d;</xref>. Mutations in the <italic>S1</italic> gene were confirmed using the OneStep RT-PCR kit (Qiagen), gene-specific primer sets, and viral dsRNA extracted from infected L cells as template. Purified PCR products were directly subjected to sequence analysis.</p></sec><sec id="s4g"><title>Reovirus Infectivity in HeLa Cells</title><p>HeLa cells (2&#x000d7;10<sup>5</sup>/well) were plated in 12-well plates and incubated at 37&#x000b0;C overnight. Cells were treated with either phosphate-buffered saline (PBS) alone (mock) or 40 mU/ml of <italic>Arthrobacter ureafasciens</italic> neuraminidase (MP Biomedicals, LLC) diluted in PBS at 37&#x000b0;C for 1 h prior to adsorption with reovirus at an MOI of 50 PFU/cell. Following incubation at 25&#x000b0;C for 1 h, cells were washed with PBS and incubated at 37&#x000b0;C for 18&#x02013;20 h. Infected cells were processed for indirect immunofluorescence as described <xref ref-type="bibr" rid="ppat.1000235-Barton2">&#x0005b;31&#x0005d;</xref>. Images were captured at 200&#x000d7; magnification using a Zeiss Axiovert 200 microscope. For each experiment, three fields of view were scored. Mean values from three independent experiments were compared using the unpaired student's <italic>t</italic> test as applied using Microsoft Excel. <italic>P</italic> values of less than 0.05 were considered statistically significant.</p></sec><sec id="s4h"><title>Reovirus Binding Assays</title><p>A BIAcore CM5 chip (GE Healthcare) was coated with mouse ascites containing monoclonal GST-specific antibody (Sigma) to &#x0223c;1800 resonance units by amine coupling. Purified GST or GST-JAM-A ectodomain fusion proteins at a concentration of 2 &#x000b5;M in HEPES-buffered saline &#x0005b;pH 7.0&#x0005d; were captured by injection across individual flow cells of an antibody-coated chip for 2.5 minutes at 20 &#x000b5;L/min using a BIAcore 2000 (GE Healthcare). Purified parent or mutant reovirus (6&#x000d7;10<sup>12</sup>, 8&#x000d7;10<sup>12</sup>, and 10<sup>13</sup> particles/mL) was injected across the conjugated chip surface at 20 &#x000b5;L/min. Following reovirus binding, chip surfaces were regenerated with a 20 &#x000b5;L pulse of 10 mM glycine &#x0005b;pH 2.5&#x0005d;. Data analysis was performed using BIAevaluation 3.0 software (GE Healthcare).</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1000235.s001"><label>Figure S1</label><caption><p>Real space correlation plots. Real space correlation plots <xref ref-type="bibr" rid="ppat.1000235-Brndn1">&#x0005b;66&#x0005d;</xref> (black) and <italic>B</italic>-factor plots (blue) for a single &#x003c3;1H chain (top) and a D1 chain (bottom). Some regions participating in contacts are shaded. The asterisk indicates the position of the 3<sub>10</sub> helix. Plots were calculated at the TB consortium bias removal server (<ext-link ext-link-type="uri" xlink:href="http://tuna.tamu.edu">http://tuna.tamu.edu</ext-link>).</p><p>(0.12 MB TIF)</p></caption><media xlink:href="ppat.1000235.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000235.s002"><label>Figure S2</label><caption><p>Ultracentrifugation experiments. (A) Sedimentation velocity experiments. Sedimentation coefficient (c(s)) distributions, with c(s) as the concentration of species with sedimentation coefficients between <italic>s</italic> and <italic>s</italic>&#x0002b;<italic>ds</italic> for five concentrations of JAM-A D1. Little change in the sedimentation coefficient of the main component around 2.35 S is observed. The small additional peak seen in variable amounts around 3.8 S likely corresponds to JAM-A D1 tetramers. The curves have been normalized to a total area of unity and offset for clarity. Note that the exact shape of the c(s)-traces depends on the signal-to-noise ratio and the detailed structure of the systematic noise from the interference data. (B) Sedimentation equilibrium results for JAM-A D1. Top panel: Raw experimental data for 17.5/25/35 krpm (black, red, and green dots, respectively) at 0.8 mg/mL together with the theoretical curves for a monomer-dimer-equilibrium (solid black lines) from which the equilibrium coefficient was derived (see text). For clarity, only every 5th data point is displayed for only one starting concentration (of four). Bottom panel: Local deviations between theoretical and experimental curves. All data points are shown. Residuals were offset by a constant factor of 0.1 for clarity.</p><p>(0.48 MB TIF)</p></caption><media xlink:href="ppat.1000235.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We acknowledge Annie Antar, Jim Chappell, and Takeshi Kobayashi for helpful discussions and ideas. We thank Dirk Reiter for generating the full-length model of &#x003c3;1 and Kenneth Martin for technical contributions.</p></ack><ref-list><title>References</title><ref id="ppat.1000235-Albelda1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albelda</surname><given-names>SM</given-names></name></person-group><year>1991</year><article-title>Endothelial and epithelial cell adhesion molecules.</article-title><source>Am J Respir Cell Mol Biol</source><volume>4</volume><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">2001288</pub-id></citation></ref><ref id="ppat.1000235-Vogelmann1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogelmann</surname><given-names>R</given-names></name><name><surname>Amieva</surname><given-names>MR</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>WJ</given-names></name></person-group><year>2004</year><article-title>Breaking into the epithelial apical-junctional complex&#x02013;news from pathogen hackers.</article-title><source>Curr Opin Cell Biol</source><volume>16</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15037310</pub-id></citation></ref><ref id="ppat.1000235-Wang1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><year>1998</year><article-title>Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses.</article-title><source>Immunol Rev</source><volume>163</volume><fpage>197</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">9700512</pub-id></citation></ref><ref id="ppat.1000235-Barton1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>ES</given-names></name><name><surname>Forrest</surname><given-names>JC</given-names></name><name><surname>Connolly</surname><given-names>JL</given-names></name><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><year>2001</year><article-title>Junction adhesion molecule is a receptor for reovirus.</article-title><source>Cell</source><volume>104</volume><fpage>441</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">11239401</pub-id></citation></ref><ref id="ppat.1000235-Makino1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>A</given-names></name><name><surname>Shimojima</surname><given-names>M</given-names></name><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Tohya</surname><given-names>Y</given-names></name><etal/></person-group><year>2006</year><article-title>Junctional adhesion molecule 1 is a functional receptor for feline calicivirus.</article-title><source>J Virol</source><volume>80</volume><fpage>4482</fpage><lpage>4490</lpage><pub-id pub-id-type="pmid">16611908</pub-id></citation></ref><ref id="ppat.1000235-Schiff1"><label>6</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schiff</surname><given-names>LA</given-names></name><name><surname>Nibert</surname><given-names>ML</given-names></name><name><surname>Tyler</surname><given-names>KL</given-names></name></person-group><year>2007</year><article-title>Orthoreoviruses and their replication.</article-title><person-group person-group-type="editor"><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name></person-group><source>Fields Virology. Fifth ed</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><fpage>1853</fpage><lpage>1915</lpage></citation></ref><ref id="ppat.1000235-Kobayashi1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Antar</surname><given-names>AAR</given-names></name><name><surname>Boehme</surname><given-names>KW</given-names></name><name><surname>Danthi</surname><given-names>P</given-names></name><name><surname>Eby</surname><given-names>EA</given-names></name><etal/></person-group><year>2007</year><article-title>Plasmid-based reverse genetics for animal double-stranded RNA viruses.</article-title><source>Cell Host Microbe</source><volume>1</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">18005692</pub-id></citation></ref><ref id="ppat.1000235-Fraser1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>RDB</given-names></name><name><surname>Furlong</surname><given-names>DB</given-names></name><name><surname>Trus</surname><given-names>BL</given-names></name><name><surname>Nibert</surname><given-names>ML</given-names></name><name><surname>Fields</surname><given-names>BN</given-names></name><etal/></person-group><year>1990</year><article-title>Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions.</article-title><source>J Virol</source><volume>64</volume><fpage>2990</fpage><lpage>3000</lpage><pub-id pub-id-type="pmid">2335824</pub-id></citation></ref><ref id="ppat.1000235-Furlong1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furlong</surname><given-names>DB</given-names></name><name><surname>Nibert</surname><given-names>ML</given-names></name><name><surname>Fields</surname><given-names>BN</given-names></name></person-group><year>1988</year><article-title>Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.</article-title><source>J Virol</source><volume>62</volume><fpage>246</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">3275434</pub-id></citation></ref><ref id="ppat.1000235-Stewart1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>PL</given-names></name><name><surname>Burnett</surname><given-names>RM</given-names></name><name><surname>Cyrklaff</surname><given-names>M</given-names></name><name><surname>Fuller</surname><given-names>SD</given-names></name></person-group><year>1991</year><article-title>Image reconstruction reveals the complex molecular organization of adenovirus.</article-title><source>Cell</source><volume>67</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">1913814</pub-id></citation></ref><ref id="ppat.1000235-Chappell1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Duong</surname><given-names>JL</given-names></name><name><surname>Wright</surname><given-names>BW</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2000</year><article-title>Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses.</article-title><source>J Virol</source><volume>74</volume><fpage>8472</fpage><lpage>8479</lpage><pub-id pub-id-type="pmid">10954547</pub-id></citation></ref><ref id="ppat.1000235-Chappell2"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Gunn</surname><given-names>VL</given-names></name><name><surname>Wetzel</surname><given-names>JD</given-names></name><name><surname>Baer</surname><given-names>GS</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>1997</year><article-title>Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein &#x003c3;1.</article-title><source>J Virol</source><volume>71</volume><fpage>1834</fpage><lpage>1841</lpage><pub-id pub-id-type="pmid">9032313</pub-id></citation></ref><ref id="ppat.1000235-Schelling1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schelling</surname><given-names>P</given-names></name><name><surname>Guglielmi</surname><given-names>KM</given-names></name><name><surname>Kirchner</surname><given-names>E</given-names></name><name><surname>Paetzold</surname><given-names>B</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name><etal/></person-group><year>2007</year><article-title>The reovirus &#x003c3;1 aspartic acid sandwich: a trimerization motif poised for conformational change.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>11582</fpage><lpage>11589</lpage><pub-id pub-id-type="pmid">17303562</pub-id></citation></ref><ref id="ppat.1000235-Chappell3"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Prota</surname><given-names>A</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name></person-group><year>2002</year><article-title>Crystal structure of reovirus attachment protein &#x003c3;1 reveals evolutionary relationship to adenovirus fiber.</article-title><source>EMBO J</source><volume>21</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11782420</pub-id></citation></ref><ref id="ppat.1000235-vanRaaij1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Raaij</surname><given-names>MJ</given-names></name><name><surname>Mitraki</surname><given-names>A</given-names></name><name><surname>Lavigne</surname><given-names>G</given-names></name><name><surname>Cusack</surname><given-names>S</given-names></name></person-group><year>1999</year><article-title>A triple &#x003b2;-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein.</article-title><source>Nature</source><volume>401</volume><fpage>935</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">10553913</pub-id></citation></ref><ref id="ppat.1000235-Merckel1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merckel</surname><given-names>MC</given-names></name><name><surname>Huiskonen</surname><given-names>JT</given-names></name><name><surname>Bamford</surname><given-names>DH</given-names></name><name><surname>Goldman</surname><given-names>A</given-names></name><name><surname>Tuma</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>The structure of the bacteriophage PRD1 spike sheds light on the evolution of viral capsid architecture.</article-title><source>Mol Cell</source><volume>18</volume><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">15837420</pub-id></citation></ref><ref id="ppat.1000235-Guardado1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guardado</surname><given-names>CP</given-names></name><name><surname>Fox</surname><given-names>GC</given-names></name><name><surname>Hermo Parrado</surname><given-names>XL</given-names></name><name><surname>Llamas-Saiz</surname><given-names>AL</given-names></name><name><surname>Costas</surname><given-names>C</given-names></name><etal/></person-group><year>2005</year><article-title>Structure of the carboxy-terminal receptor-binding domain of avian reovirus fibre sigmaC.</article-title><source>J Mol Biol</source><volume>354</volume><fpage>137</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">16236316</pub-id></citation></ref><ref id="ppat.1000235-Liu1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name><name><surname>Schnell</surname><given-names>FJ</given-names></name><name><surname>Reaves</surname><given-names>TA</given-names></name><name><surname>Walsh</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Human junction adhesion molecule regulates tight junction resealing in epithelia.</article-title><source>J Cell Sci</source><volume>113</volume><fpage>2363</fpage><lpage>2374</lpage><pub-id pub-id-type="pmid">10852816</pub-id></citation></ref><ref id="ppat.1000235-MartinPadura1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin-Padura</surname><given-names>I</given-names></name><name><surname>Lostaglio</surname><given-names>S</given-names></name><name><surname>Schneemann</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Romano</surname><given-names>M</given-names></name><etal/></person-group><year>1998</year><article-title>Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration.</article-title><source>J Cell Biol</source><volume>142</volume><fpage>117</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">9660867</pub-id></citation></ref><ref id="ppat.1000235-Williams1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LA</given-names></name><name><surname>Martin-Padura</surname><given-names>I</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name></person-group><year>1999</year><article-title>Identification and characterisation of human junctional adhesion molecule (JAM).</article-title><source>Mol Immunol</source><volume>36</volume><fpage>1175</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">10698320</pub-id></citation></ref><ref id="ppat.1000235-DelMaschio1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Maschio</surname><given-names>A</given-names></name><name><surname>De Luigi</surname><given-names>A</given-names></name><name><surname>Martin-Padura</surname><given-names>I</given-names></name><name><surname>Brockhaus</surname><given-names>M</given-names></name><name><surname>Bartfai</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).</article-title><source>J Exp Med</source><volume>190</volume><fpage>1351</fpage><lpage>1356</lpage><pub-id pub-id-type="pmid">10544206</pub-id></citation></ref><ref id="ppat.1000235-Woodfin1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woodfin</surname><given-names>A</given-names></name><name><surname>Reichel</surname><given-names>CA</given-names></name><name><surname>Khandoga</surname><given-names>A</given-names></name><name><surname>Corada</surname><given-names>M</given-names></name><name><surname>Voisin</surname><given-names>MB</given-names></name><etal/></person-group><year>2007</year><article-title>JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration.</article-title><source>Blood</source><volume>110</volume><fpage>1848</fpage><lpage>1856</lpage><pub-id pub-id-type="pmid">17505016</pub-id></citation></ref><ref id="ppat.1000235-Kostrewa1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kostrewa</surname><given-names>D</given-names></name><name><surname>Brockhaus</surname><given-names>M</given-names></name><name><surname>D'Arcy</surname><given-names>A</given-names></name><name><surname>Dale</surname><given-names>GE</given-names></name><name><surname>Nelboeck</surname><given-names>P</given-names></name><etal/></person-group><year>2001</year><article-title>X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif.</article-title><source>EMBO J</source><volume>20</volume><fpage>4391</fpage><lpage>4398</lpage><pub-id pub-id-type="pmid">11500366</pub-id></citation></ref><ref id="ppat.1000235-Prota1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>AE</given-names></name><name><surname>Campbell</surname><given-names>JA</given-names></name><name><surname>Schelling</surname><given-names>P</given-names></name><name><surname>Forrest</surname><given-names>JC</given-names></name><name><surname>Peters</surname><given-names>TR</given-names></name><etal/></person-group><year>2003</year><article-title>Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>5366</fpage><lpage>5371</lpage><pub-id pub-id-type="pmid">12697893</pub-id></citation></ref><ref id="ppat.1000235-vanRaaij2"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Raaij</surname><given-names>MJ</given-names></name><name><surname>Chouin</surname><given-names>E</given-names></name><name><surname>van der Zandt</surname><given-names>H</given-names></name><name><surname>Bergelson</surname><given-names>JM</given-names></name><name><surname>Cusack</surname><given-names>S</given-names></name></person-group><year>2000</year><article-title>Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution.</article-title><source>Structure</source><volume>8</volume><fpage>1147</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">11080637</pub-id></citation></ref><ref id="ppat.1000235-Forrest1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>JC</given-names></name><name><surname>Campbell</surname><given-names>JA</given-names></name><name><surname>Schelling</surname><given-names>P</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2003</year><article-title>Structure-function analysis of reovirus binding to junctional adhesion molecule 1. Implications for the mechanism of reovirus attachment.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>48434</fpage><lpage>48444</lpage><pub-id pub-id-type="pmid">12966102</pub-id></citation></ref><ref id="ppat.1000235-Guglielmi1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guglielmi</surname><given-names>KM</given-names></name><name><surname>Kirchner</surname><given-names>E</given-names></name><name><surname>Holm</surname><given-names>GH</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2007</year><article-title>Reovirus binding determinants in junctional adhesion molecule-A.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>17930</fpage><lpage>17940</lpage><pub-id pub-id-type="pmid">17452315</pub-id></citation></ref><ref id="ppat.1000235-Matthews1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>BW</given-names></name></person-group><year>1968</year><article-title>Solvent content of protein crystals.</article-title><source>J Mol Biol</source><volume>33</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">5700707</pub-id></citation></ref><ref id="ppat.1000235-Rodgers1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>DW</given-names></name></person-group><year>1994</year><article-title>Cryocrystallography.</article-title><source>Structure</source><volume>2</volume><fpage>1135</fpage><lpage>1140</lpage><pub-id pub-id-type="pmid">7704524</pub-id></citation></ref><ref id="ppat.1000235-Bazzoni1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bazzoni</surname><given-names>G</given-names></name><name><surname>Martinez-Estrada</surname><given-names>OM</given-names></name><name><surname>Mueller</surname><given-names>F</given-names></name><name><surname>Nelboeck</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>G</given-names></name><etal/></person-group><year>2000</year><article-title>Homophilic interaction of junctional adhesion molecule.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>30970</fpage><lpage>30976</lpage><pub-id pub-id-type="pmid">10913139</pub-id></citation></ref><ref id="ppat.1000235-Barton2"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>ES</given-names></name><name><surname>Connolly</surname><given-names>JL</given-names></name><name><surname>Forrest</surname><given-names>JC</given-names></name><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2001</year><article-title>Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>2200</fpage><lpage>2211</lpage><pub-id pub-id-type="pmid">11054410</pub-id></citation></ref><ref id="ppat.1000235-Campbell1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JA</given-names></name><name><surname>Shelling</surname><given-names>P</given-names></name><name><surname>Wetzel</surname><given-names>JD</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Wilson</surname><given-names>GAR</given-names></name><etal/></person-group><year>2005</year><article-title>Junctional adhesion molecule-A serves as a receptor for prototype and field-isolate strains of mammalian reovirus.</article-title><source>J Virol</source><volume>79</volume><fpage>7967</fpage><lpage>7978</lpage><pub-id pub-id-type="pmid">15956543</pub-id></citation></ref><ref id="ppat.1000235-Kleywegt1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleywegt</surname><given-names>GJ</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name></person-group><year>1994</year><article-title>Detection, delineation, measurement and display of cavities in macromolecular structures.</article-title><source>Acta Crystallogr D Biol Crystallogr</source><volume>50</volume><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">15299456</pub-id></citation></ref><ref id="ppat.1000235-Guglielmi2"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guglielmi</surname><given-names>KM</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2006</year><article-title>Attachment and cell entry of mammalian orthoreovirus.</article-title><source>Curr Top Microbiol Immunol</source><volume>309</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16909895</pub-id></citation></ref><ref id="ppat.1000235-Wu1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Von Seggern</surname><given-names>DJ</given-names></name><name><surname>Mullen</surname><given-names>TM</given-names></name><name><surname>Mikyas</surname><given-names>Y</given-names></name><etal/></person-group><year>2003</year><article-title>Flexibility of the adenovirus fiber is required for efficient receptor interaction.</article-title><source>J Virol</source><volume>77</volume><fpage>7225</fpage><lpage>7235</lpage><pub-id pub-id-type="pmid">12805421</pub-id></citation></ref><ref id="ppat.1000235-Stehle1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2003</year><article-title>Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins.</article-title><source>Rev Med Virol</source><volume>13</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">12627395</pub-id></citation></ref><ref id="ppat.1000235-Stehle2"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name></person-group><year>2004</year><article-title>Structural similarities in the cellular receptors used by adenovirus and reovirus.</article-title><source>Viral Immunol</source><volume>17</volume><fpage>129</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">15279694</pub-id></citation></ref><ref id="ppat.1000235-Bewley1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bewley</surname><given-names>MC</given-names></name><name><surname>Springer</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>YB</given-names></name><name><surname>Freimuth</surname><given-names>P</given-names></name><name><surname>Flanagan</surname><given-names>JM</given-names></name></person-group><year>1999</year><article-title>Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR.</article-title><source>Science</source><volume>286</volume><fpage>1579</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">10567268</pub-id></citation></ref><ref id="ppat.1000235-Kirby1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirby</surname><given-names>I</given-names></name><name><surname>Davison</surname><given-names>E</given-names></name><name><surname>Beavil</surname><given-names>AJ</given-names></name><name><surname>Soh</surname><given-names>CP</given-names></name><name><surname>Wickham</surname><given-names>TJ</given-names></name><etal/></person-group><year>2000</year><article-title>Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein.</article-title><source>J Virol</source><volume>74</volume><fpage>2804</fpage><lpage>2813</lpage><pub-id pub-id-type="pmid">10684297</pub-id></citation></ref><ref id="ppat.1000235-Bergelson1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergelson</surname><given-names>JM</given-names></name><name><surname>Cunningham</surname><given-names>JA</given-names></name><name><surname>Droguett</surname><given-names>G</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Krithivas</surname><given-names>A</given-names></name><etal/></person-group><year>1997</year><article-title>Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.</article-title><source>Science</source><volume>275</volume><fpage>1320</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">9036860</pub-id></citation></ref><ref id="ppat.1000235-He1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Chipman</surname><given-names>PR</given-names></name><name><surname>Howitt</surname><given-names>J</given-names></name><name><surname>Bator</surname><given-names>CM</given-names></name><name><surname>Whitt</surname><given-names>MA</given-names></name><etal/></person-group><year>2001</year><article-title>Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.</article-title><source>Nat Struct Biol</source><volume>8</volume><fpage>874</fpage><lpage>878</lpage><pub-id pub-id-type="pmid">11573093</pub-id></citation></ref><ref id="ppat.1000235-Ossiboff1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ossiboff</surname><given-names>RJ</given-names></name><name><surname>Parker</surname><given-names>JS</given-names></name></person-group><year>2007</year><article-title>Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.</article-title><source>J Virol</source><volume>81</volume><fpage>13608</fpage><lpage>13621</lpage><pub-id pub-id-type="pmid">17913818</pub-id></citation></ref><ref id="ppat.1000235-Bhella1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhella</surname><given-names>D</given-names></name><name><surname>Gatherer</surname><given-names>D</given-names></name><name><surname>Chaudhry</surname><given-names>Y</given-names></name><name><surname>Pink</surname><given-names>R</given-names></name><name><surname>Goodfellow</surname><given-names>IG</given-names></name></person-group><year>2008</year><article-title>Structural insights into calicivirus attachment and uncoating.</article-title><source>J Virol</source><volume>82</volume><fpage>8051</fpage><lpage>8058</lpage><pub-id pub-id-type="pmid">18550656</pub-id></citation></ref><ref id="ppat.1000235-Mercier1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mercier</surname><given-names>GT</given-names></name><name><surname>Campbell</surname><given-names>JA</given-names></name><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name><etal/></person-group><year>2004</year><article-title>A chimeric adenovirus vector encoding reovirus attachment protein &#x003c3;1 targets cells expressing junctional adhesion molecule 1.</article-title><source>Proc Natl Acad Sci USA</source><volume>101</volume><fpage>6188</fpage><lpage>6193</lpage><pub-id pub-id-type="pmid">15079060</pub-id></citation></ref><ref id="ppat.1000235-Forsyth1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsyth</surname><given-names>P</given-names></name><name><surname>Roldan</surname><given-names>G</given-names></name><name><surname>George</surname><given-names>D</given-names></name><name><surname>Wallace</surname><given-names>C</given-names></name><name><surname>Palmer</surname><given-names>CA</given-names></name><etal/></person-group><year>2008</year><article-title>A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.</article-title><source>Mol Ther</source><volume>16</volume><fpage>627</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">18253152</pub-id></citation></ref><ref id="ppat.1000235-Liu2"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>TC</given-names></name><name><surname>Kirn</surname><given-names>D</given-names></name></person-group><year>2007</year><article-title>Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.</article-title><source>Cancer Res</source><volume>67</volume><fpage>429</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">17234747</pub-id></citation></ref><ref id="ppat.1000235-Norman1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>KL</given-names></name><name><surname>Lee</surname><given-names>PW</given-names></name></person-group><year>2000</year><article-title>Reovirus as a novel oncolytic agent.</article-title><source>J Clin Invest</source><volume>105</volume><fpage>1035</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">10772645</pub-id></citation></ref><ref id="ppat.1000235-Parato1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parato</surname><given-names>KA</given-names></name><name><surname>Senger</surname><given-names>D</given-names></name><name><surname>Forsyth</surname><given-names>PA</given-names></name><name><surname>Bell</surname><given-names>JC</given-names></name></person-group><year>2005</year><article-title>Recent progress in the battle between oncolytic viruses and tumours.</article-title><source>Nat Rev Cancer</source><volume>5</volume><fpage>965</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">16294217</pub-id></citation></ref><ref id="ppat.1000235-Wilcox1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>ME</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Senger</surname><given-names>D</given-names></name><name><surname>Rewcastle</surname><given-names>NB</given-names></name><name><surname>Morris</surname><given-names>DG</given-names></name><etal/></person-group><year>2001</year><article-title>Reovirus as an oncolytic agent against experimental human malignant gliomas.</article-title><source>J Natl Cancer Inst</source><volume>93</volume><fpage>903</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">11416111</pub-id></citation></ref><ref id="ppat.1000235-Kwong1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>PD</given-names></name><name><surname>Wyatt</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Sweet</surname><given-names>RW</given-names></name><name><surname>Sodroski</surname><given-names>J</given-names></name><etal/></person-group><year>1998</year><article-title>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing antibody.</article-title><source>Nature</source><volume>393</volume><fpage>648</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">9641677</pub-id></citation></ref><ref id="ppat.1000235-Bella1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bella</surname><given-names>J</given-names></name><name><surname>Kolatkar</surname><given-names>PR</given-names></name><name><surname>Marlor</surname><given-names>CW</given-names></name><name><surname>Greve</surname><given-names>JM</given-names></name><name><surname>Rossmann</surname><given-names>MG</given-names></name></person-group><year>1998</year><article-title>The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.</article-title><source>Proceedings of the National Academy of Sciences</source><volume>95</volume><fpage>4140</fpage><lpage>4145</lpage></citation></ref><ref id="ppat.1000235-Miller1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Knorr</surname><given-names>R</given-names></name><name><surname>Ferrone</surname><given-names>M</given-names></name><name><surname>Houdei</surname><given-names>R</given-names></name><name><surname>Carron</surname><given-names>CP</given-names></name><etal/></person-group><year>1995</year><article-title>Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1.</article-title><source>J Exp Med</source><volume>182</volume><fpage>1231</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">7595194</pub-id></citation></ref><ref id="ppat.1000235-Wu2"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Kwong</surname><given-names>PD</given-names></name><name><surname>Hendrickson</surname><given-names>WA</given-names></name></person-group><year>1997</year><article-title>Dimeric association and segmental variability in the structure of human CD4.</article-title><source>Nature</source><volume>387</volume><fpage>527</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">9168119</pub-id></citation></ref><ref id="ppat.1000235-Bowden1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>TA</given-names></name><name><surname>Aricescu</surname><given-names>AR</given-names></name><name><surname>Gilbert</surname><given-names>RJ</given-names></name><name><surname>Grimes</surname><given-names>JM</given-names></name><name><surname>Jones</surname><given-names>EY</given-names></name><etal/></person-group><year>2008</year><article-title>Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.</article-title><source>Nat Struct Mol Biol</source><volume>15</volume><fpage>567</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">18488039</pub-id></citation></ref><ref id="ppat.1000235-CCP41"><label>55</label><citation citation-type="journal"><collab>CCP4</collab><year>1994</year><article-title>The CCP4 suite: programs for protein crystallography.</article-title><source>Acta Crystallogr D</source><volume>50</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">15299374</pub-id></citation></ref><ref id="ppat.1000235-Brnger1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000fc;nger</surname><given-names>AT</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name><name><surname>DeLano</surname><given-names>WL</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name><etal/></person-group><year>1998</year><article-title>Crystallography &#x00026; NMR system: A new software suite for macromolecular structure determination.</article-title><source>Acta Crystallogr <italic>D</italic></source><volume>54</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">9757107</pub-id></citation></ref><ref id="ppat.1000235-Emsley1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Coot: model building tools for molecular graphics.</article-title><source>Acta Crystallogr D Biol Crystallogr</source><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="pmid">15572765</pub-id></citation></ref><ref id="ppat.1000235-Kleywegt2"><label>58</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kleywegt</surname><given-names>GJ</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name></person-group><year>1994</year><article-title>Halloween - masks and bones.</article-title><person-group person-group-type="editor"><name><surname>Bailey</surname><given-names>S</given-names></name><name><surname>Hubbard</surname><given-names>R</given-names></name><name><surname>Waller</surname><given-names>D</given-names></name></person-group><source>From first map to final model</source><publisher-loc>Warrington (UK)</publisher-loc><publisher-name>SERC Daresbury Laboratory</publisher-name><fpage>59</fpage><lpage>66</lpage></citation></ref><ref id="ppat.1000235-Gamblin1"><label>59</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gamblin</surname><given-names>SJ</given-names></name><name><surname>Rodgers</surname><given-names>DW</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name></person-group><year>1996</year><article-title>Improving electron density maps calculated from weak or anisotropic data.</article-title><source>Proceedings of the CCP4 Study Weekend</source><publisher-loc>Daresbury, UK</publisher-loc><publisher-name>Daresbury Laboratory</publisher-name><fpage>160</fpage><lpage>163</lpage></citation></ref><ref id="ppat.1000235-DeLano1"><label>60</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>DeLano</surname><given-names>WL</given-names></name></person-group><year>2002</year><source>The PyMOL Molecular Graphics System</source><publisher-loc>San Carlos, USA</publisher-loc><publisher-name>DeLano Scientific</publisher-name></citation></ref><ref id="ppat.1000235-Schuck1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuck</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.</article-title><source>Biophys J</source><volume>78</volume><fpage>1606</fpage><lpage>1619</lpage><pub-id pub-id-type="pmid">10692345</pub-id></citation></ref><ref id="ppat.1000235-Virgin1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Virgin</surname><given-names>HW</given-names><suffix>IV</suffix></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Fields</surname><given-names>BN</given-names></name><name><surname>Tyler</surname><given-names>KL</given-names></name></person-group><year>1988</year><article-title>Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).</article-title><source>J Virol</source><volume>62</volume><fpage>4594</fpage><lpage>4604</lpage><pub-id pub-id-type="pmid">2460637</pub-id></citation></ref><ref id="ppat.1000235-Ishii1"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Kitamura</surname><given-names>T</given-names></name><etal/></person-group><year>2002</year><article-title>Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector.</article-title><source>Virology</source><volume>302</volume><fpage>433</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">12441087</pub-id></citation></ref><ref id="ppat.1000235-Lerner1"><label>64</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>MG</given-names></name><name><surname>Carlson</surname><given-names>HA</given-names></name></person-group><year>2006</year><source>APBS plugin for PyMOL</source><publisher-loc>Ann Arbor</publisher-loc><publisher-name>University of Michigan</publisher-name></citation></ref><ref id="ppat.1000235-Brnger2"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000fc;nger</surname><given-names>AT</given-names></name></person-group><year>1992</year><article-title>Free <italic>R</italic> value: a novel statistical quantity for assessing the accuracy of crystal structures.</article-title><source>Nature</source><volume>355</volume><fpage>472</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">18481394</pub-id></citation></ref><ref id="ppat.1000235-Brndn1"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000e4;nd&#x000e9;n</surname><given-names>C-I</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name></person-group><year>1990</year><article-title>Between objectivity and subjectivity.</article-title><source>Nature</source><volume>343</volume><fpage>687</fpage><lpage>689</lpage></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This work was supported by Public Health Service awards T32 GM08554 (K.M.G.), R37 AI38296 (T.S.D.), and R01 GM67853/AI76983 (T.S.D. and T.S.) and the Elizabeth B. Lamb Center for Pediatric Research. Additional support was provided by Public Health Service awards P30 CA68485 for the Vanderbilt-Ingram Cancer Center and P60 DK20593 for the Vanderbilt Diabetes Research and Training Center.</p></fn></fn-group></back></article> 